Compare ARK Genomic Revolution ETF (ARKG) vs NIO Inc. (NIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs NIO Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while NIO Inc. trades at $4.87 (market cap $12.35B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | NIO | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $7.89 |
52-Week Low | $23.09 | $3.90 |
Market Cap | — | $12.35B |
Enterprise Value | — | $11.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NIO trades at $4.78, unchanged on the day, with a bearish technical signal from moving averages. Revenue grew to $87.49B in 2025, but net losses persist at -$15.57B, though margins improved. Vehicle deliveries surged 62.9% year-over-year in June 2026, driven by strong ES9 performance. Cash flow remains negative, with a net cash outflow of -$10.87B in 2024.
The outlook is mixed: robust delivery growth and narrowing losses signal operational progress, but persistent cash burn and high debt pose risks. Analyst consensus leans bullish with 50% buy ratings, yet the stock faces headwinds from competitive pressures and macroeconomic concerns affecting Chinese EV stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
